Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008–2012
Filetype[PDF-471.95 KB]


Details:
  • Alternative Title:
    Int J Stroke
  • Personal Author:
  • Description:
    Background

    Limited studies exist on the outcome of thrombolytic therapy of acute ischemic stroke patients outside of clinical trials.

    Aim

    To assess the possible risk factors associated with in-hospital death and symptomatic intracerebral hemorrhage among patients who received intravenous tissue plasminogen activator.

    Methods

    A total of 7193 patients with a clinical diagnosis of acute ischemic stroke and a documented National Institutes of Health Stroke Scale score were treated with intravenous tissue plasminogen activator within 4·5 hours of time last known to be well. Generalized estimating equations modeling was used to assess the associations of in-hospital death and symptomatic intracerebral hemorrhage with clinical characteristics.

    Results

    Among 7193 patients treated with intravenous tissue plasminogen activator, 516 (7·2%) died during hospitalization. Factors associated with in-hospital death were older age, male gender, National Institutes of Health Stroke Scale score, history of myocardial infarction or coronary artery disease, and history of nonvalvular atrial fibrillation. Increasing age, higher National Institutes of Health Stroke Scale score, and history of dyslipidemia were associated with symptomatic intracerebral hemorrhage. There was no difference in the rates of in-hospital death or symptomatic intracerebral hemorrhage among patients treated with intravenous tissue plasminogen activator within three-hours of time last known to be well and those treated between three and 4·5 hours after this time.

    Conclusions

    In this study of acute ischemic stroke patients, older age, male gender, National Institutes of Health Stroke Scale score, history of myocardial infarction or coronary artery disease, and history of atrial fibrillation were associated with increased in-hospital death among patients receiving intravenous tissue plasminogen activator. Among patients treated with intravenous tissue plasminogen activator, in-hospital mortality and symptomatic intracerebral hemorrhage rates were similar between those treated within three-hours of time last known to be well and those treated between three and 4·5 hours after this time.

  • Subject:
  • Pubmed ID:
    24024962
  • Pubmed Central ID:
    PMC4451118
  • Document Type:
    Journal Article
  • Funding:
    CC999999/Intramural CDC HHS/United States
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
No Related Documents.
You May Also Like:
  1. Paul Coverdell National Acute Stroke Registry Surveillance -- four States, 2005-2007
    Personal Author:
    Hinchey, Judith; George, Mary G.; McGruder, Henraya; Pandey, Dilip K.; Rosamond, Wayne; Tong, Xin; Wall, Hilary K.; Winquist, Andrea; Yoon, Paula W.;
    Corporate Authors:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.). Centers for Disease Control and Prevention (U.S.).
    Published Date:
    November 6, 2009
    Series:
    MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries ; v. 58, no. SS-7
    Description:
    "Problem/Condition: Each year, approximately 795,000 persons in the United States experience a new or recurrent stroke. Data from the prototype phase (2001--2004) of the Paul Coverdell National Acute Stroke Registry (PCNASR) suggested that numerous a...
    File Type:
    Filetype[PDF - 377.01 KB]
  2. Acute Stroke Reperfusion Therapy Trends in the Expanded Treatment Window Era
    Personal Author:
    Asaithambi, Ganesh; Tong, Xin; George, Mary G.; Tsai, Albert W.; Peacock, James M.; Luepker, Russell V.; Lakshminarayan, Kamakshi;
    Published Date:
    Aug 23 2014
    Source:
    J Stroke Cerebrovasc Dis. 2014; 23(9):2316-2321.
    Description:
    BackgroundThe American Heart Association/American Stroke Association (AHA/ ASA) recommended an expansion of the time window for acute ischemic stroke (AIS) reperfusion with intravenous (IV) recombinant tissue plasminogen activator (rt-PA) from 3 to 4...
    File Type:
    Filetype[PDF - 477.21 KB]
  3. Paul Coverdell National Acute Stroke Registry Program summary report, 2007–2012
    Corporate Authors:
    Paul Coverdell National Acute Stroke Registry Program.. National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division for Heart Disease & Stroke Prevention.. Centers for Disease Control and Prevention (U.S.).
    Published Date:
    1/2015
    Description:
    This summary report presents an overview of the Paul Coverdell National Acute Stroke Registry program and six vignettes of specific programmatic strategies and activities employed by states funded by the Centers for Disease Control and Prevention (CD...
    File Type:
    Filetype[PDF - 651.29 KB]
  4. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017
    Personal Author:
    Tong, Xin; Wiltz, Jennifer L.; George, Mary G.; Odom, Erika C.; King, Sallyann M. Coleman; Chang, Tiffany; Yin, Xiaoping; Merritt, Robert K.;
    Corporate Authors:
    Paul Coverdell National Acute Stroke Program team
    Published Date:
    Dec 2018
    Source:
    Circ Cardiovasc Qual Outcomes. 11(12):e004981
    Description:
    BACKGROUND:The clinical benefit of intravenous (IV) alteplase in acute ischemic stroke is time dependent. We assessed the overall temporal changes in door-to-needle (DTN) time and examine the factors associated with DTN time ≤60 and ≤45 minutes.M...
    File Type:
    Filetype[PDF - 1.50 MB]
  5. Paul Coverdell National Acute Stroke Registry
    Corporate Authors:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division for Heart Disease & Stroke Prevention.
    Published Date:
    12/8/10
    Description:
    Each year, more than 700,000 Americans suffer from a stroke; about 25% of them die at the time of the event or soon after, and 15%–30% of survivors remain permanently disabled. More than 1 million Americans and their families live with the disablin...
    File Type:
    Filetype[PDF - 1.20 MB]